Archives

by in
Entry Author Date Location
Ariosa Takes Pre-Natal Genetic Test to Wall Street, Eyes $69M IPO 03/25/14 San Francisco
Miscarriage Mysteries Create New Market for Natera 02/12/14 San Francisco
Cellscape Hunts for Fetal Cells in Mom, Pushing Diagnostic Frontier 08/21/13 San Francisco
Natera Grabs $55M For Push into Prenatal Genetic Screening 05/01/13 San Francisco
Natera Secures $54,600,000 Series E Financing 05/01/13 San Francisco
Six Reasons Why Illumina Has Nothing to Fear from Thermo/Life 04/29/13 National
San Diego Life Sciences Roundup: IPOs, ResMed, Ventrix, CovX, & More 02/21/13 San Diego
Natera Joins Quest in Four-Way Battle for Prenatal Genetic Tests 02/20/13 San Francisco
Illumina Acquires Verinata Health, Prenatal Testmaker, For $350M 01/07/13 San Diego
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Verinata’s Big Day Arrives, With Prenatal Down Syndrome Test Debut 02/29/12 San Francisco
Gene Security Network, Now Natera, Adds $20M For Prenatal Tests 01/06/12 San Francisco
Natera Lands $20,000,000 New Financing Round 01/06/12 San Francisco
Page 1 of 1